Katie Cohen

The Bounded Triumph of Health Care Ballot Initiatives

The Bounded Triumph of Health Care Ballot Initiatives

Medicaid expansion ballot initiatives show state referenda can expand health care access—but they have their limits.

Cutting Corners on COVID-19 Treatments?

Cutting Corners on COVID-19 Treatments?

Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.

HHS Selects Drugs for Medicare Price Negotiation

HHS Selects Drugs for Medicare Price Negotiation

Biden Administration introduces price regulation to the pharmaceutical industry.

Cracking Down on Overdose Deaths

Cracking Down on Overdose Deaths

FDA approves first over-the-counter treatment to combat the opioid overdose epidemic.

Drug Safety, or Overregulation of Reproductive Health?

Drug Safety, or Overregulation of Reproductive Health?

Scholar calls for FDA to remove stringent restrictions on medication abortion.

Underrepresented, Overmedicated, and Misdiagnosed

Underrepresented, Overmedicated, and Misdiagnosed

Experts contend that FDA clinical trials fail to ensure adequate consideration of women’s health needs.

The Borders of the U.S. Health Care System

The Borders of the U.S. Health Care System

Scholars explore regulatory reforms to expand noncitizens’ access to health care.

Regulating ESG Disclosure

Regulating ESG Disclosure

Experts explore the evolving sphere of ESG regulation in light of greater calls for corporate accountability.

(Un)Equal Pay for Equal Work

(Un)Equal Pay for Equal Work

Scholars examine regulatory approaches to achieving pay equity.

A Game of Inches for Youth Concussion Regulation

A Game of Inches for Youth Concussion Regulation

Experts explore the impact of concussion legislation on adolescent health and education.

Getting Disinformation Right

Getting Disinformation Right

In this week’s Saturday Seminar, scholars explore the challenges and potential for regulating disinformation.

Regulating Supervised Consumption Services

Regulating Supervised Consumption Services

Experts discuss the role of regulations in monitoring experimental overdose prevention programs.